Wingert William E, Mundy Lisa A, Collins Gary L, Chmara Edward S
Medical Examiners Office, 321 University Avenue, Philadelphia, PA 19104, USA.
J Forensic Sci. 2007 Mar;52(2):487-90. doi: 10.1111/j.1556-4029.2007.00391.x.
The Philadelphia Medical Examiners Office has reported a series of 15 deaths between February 1999 and June 2005 of infants and toddlers 16 months and younger in which drugs commonly found in over-the-counter (OTC) cold medications were present. A total of 10 different drugs were detected: pseudoephedrine, dextromethorphan, acetaminophen, brompheniramine, carbinoxamine, chlorpheniramine, ethanol, doxylamine and the anticonvulsants, phenobarbital, and phenytoin. The drugs were confirmed and quantified by gas chromatography (GC)-mass spectrometry, with the exception of ethanol, which was analyzed by headspace GC and of phenobarbital and phenytoin that were quantified by GC with a nitrogen phosphorus detector. The most predominant drug was pseudoephedrine, which was found in all of the cases (blood concentration, n=14, range=0.10-17.0 mg/L, mean=3.34 mg/L) and was the sole drug detected in three cases. Acetaminophen was detected in blood from each of the five cases with sufficient sample. Other drugs (with frequency of detection) were dextromethorphan (five cases), carbinoxamine (four cases), chlorpheniramine (two cases) and brompheniramine, doxylamine, and ethanol (one case each). In the majority of the cases, toxicity from drugs found in easily available OTC medications was listed either as the direct cause of death or as a contributory factor. The manner of death was determined to be natural in only two of the cases. This postmortem study supports previous evidence that the administration of OTC cold medications to infants may, under some circumstances, be an unsafe practice and in some cases may even be fatal. The treating physicians and the general public need to be made more aware of the dangers of using OTC cold medications to treat very young children so that these types of tragedies might be avoided.
费城法医办公室报告了1999年2月至2005年6月期间16个月及以下婴幼儿的一系列15起死亡事件,这些婴幼儿体内存在非处方(OTC)感冒药中常见的药物。总共检测到10种不同的药物:伪麻黄碱、右美沙芬、对乙酰氨基酚、溴苯那敏、卡比沙明、氯苯那敏、乙醇、多西拉敏以及抗惊厥药苯巴比妥和苯妥英钠。除乙醇通过顶空气相色谱法分析以及苯巴比妥和苯妥英钠通过带氮磷检测器的气相色谱法定量外,其他药物均通过气相色谱(GC)-质谱法进行确认和定量。最主要的药物是伪麻黄碱,所有病例中均检测到该药物(血药浓度,n = 14,范围 = 0.10 - 17.0 mg/L,平均值 = 3.34 mg/L),且有3例仅检测到该药物。在有足够样本的5例病例中,均在血液中检测到了对乙酰氨基酚。其他药物(检测频率)有右美沙芬(5例)、卡比沙明(4例)、氯苯那敏(2例)以及溴苯那敏、多西拉敏和乙醇(各1例)。在大多数病例中,容易获得的OTC药物中所含药物的毒性被列为直接死因或促成因素。仅2例病例的死亡方式被判定为自然死亡。这项尸检研究支持了先前的证据,即在某些情况下,给婴儿服用OTC感冒药可能是不安全的做法,在某些情况下甚至可能致命。需要让治疗医生和公众更加了解使用OTC感冒药治疗幼儿的危险性,以便避免此类悲剧的发生。